The pivotal role of FDG-PET/CT in modern medicine
S Hess, BA Blomberg, HJ Zhu, PF Høilund-Carlsen… - Academic radiology, 2014 - Elsevier
The technology behind positron emission tomography (PET) and the most widely used
tracer, 2-deoxy-2-[18F] fluoro-D-glucose (FDG), were both conceived in the 1970s, but the …
tracer, 2-deoxy-2-[18F] fluoro-D-glucose (FDG), were both conceived in the 1970s, but the …
PET/CT scanner instrumentation, challenges, and solutions
PET radiotracer imaging with the labeled glucose analogue [18F]-fluorodeoxyglucose (FDG)
is increasingly being used in oncology imaging because of its usefulness in detecting and …
is increasingly being used in oncology imaging because of its usefulness in detecting and …
FDG PET/CT in oncology:“raising the bar”
CN Patel, AR Goldstone, FU Chowdhury… - Clinical radiology, 2010 - Elsevier
Integrated positron-emission tomography/computed tomography (PET/CT) with 2-[18F]-
fluoro-2-deoxy-d-glucose (FDG) has revolutionized oncological imaging in recent years and …
fluoro-2-deoxy-d-glucose (FDG) has revolutionized oncological imaging in recent years and …
Role of 18F‐FDOPA PET/CT imaging in endocrinology
P Santhanam, D Taïeb - Clinical endocrinology, 2014 - Wiley Online Library
Summary 18F‐FDOPA (6‐[18F]‐L‐fluoro‐L‐3, 4‐dihydroxyphenylalanine)‐based PET/CT
imaging can be a useful tool for the detection of different neuroendocrine tumours (NETs) …
imaging can be a useful tool for the detection of different neuroendocrine tumours (NETs) …
6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications
PL Jager, R Chirakal, CJ Marriott… - Journal of nuclear …, 2008 - Soc Nuclear Med
In recent years, 6-l-18F-fluorodihydroxyphenylalanine (18F-DOPA) PET has emerged as a
new diagnostic tool for the imaging of neuroendocrine tumors. This application is based on …
new diagnostic tool for the imaging of neuroendocrine tumors. This application is based on …
Heterogeneous Uptake of 68Ga-DOTATATE and 18F-FDG in Initial Diagnosed Neuroendocrine Tumors Patients: Which Patients Are Suitable for Dual-Tracer PET …
Y Zhou, L Li, H Wang, H Huang, D Cao… - Clinical Nuclear …, 2024 - journals.lww.com
Purpose This study was designed to assess the uptake heterogeneity in neuroendocrine
tumor (NET) patients at initial diagnosis with dual-tracer PET imaging and the staging …
tumor (NET) patients at initial diagnosis with dual-tracer PET imaging and the staging …
18 F-Meta Fluorobenzyl Guanidine (MFBG) PET imaging in patients with Neuroendocrine malignancies: Biodistribution, Pharmacokinetics, Organ dosimetry and …
N Pandit-Taskar, P Zanzonico, D Reidy-Lagunes… - 2016 - Soc Nuclear Med
25 Objectives 123 I-MIBG imaging for neuroendocrine tumors (NET) has several limitations
including a two day imaging schedule, need for thyroid blockage with SSKI, lower resolution …
including a two day imaging schedule, need for thyroid blockage with SSKI, lower resolution …
PET with different radiopharmaceuticals in neuroendocrine neoplasms: An umbrella review of published meta-analyses
Simple Summary Functional imaging methods and, in particular, positron emission
tomography (PET) using several radiopharmaceuticals may play a pivotal role in patients …
tomography (PET) using several radiopharmaceuticals may play a pivotal role in patients …
[PDF][PDF] An Overview about PET Imaging of primary bone tumors
AF Salem, KA Ibrahim, DH Ebrahim… - afjbs.com
Primary malignant bone tumors are fairly rare. The most common primary malignant bone
tumors are osteosarcoma, chondrosarcoma, and Ewing's sarcoma. Staging of the disease is …
tumors are osteosarcoma, chondrosarcoma, and Ewing's sarcoma. Staging of the disease is …